<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1989-07-01" modified="2020-10-07" version="249">
<accession>P10276</accession>
<accession>B8Y636</accession>
<accession>P78456</accession>
<accession>Q13440</accession>
<accession>Q13441</accession>
<accession>Q96S41</accession>
<accession>Q9NQS0</accession>
<name>RARA_HUMAN</name>
<protein>
<recommendedName>
<fullName>Retinoic acid receptor alpha</fullName>
<shortName>RAR-alpha</shortName>
</recommendedName>
<alternativeName>
<fullName>Nuclear receptor subfamily 1 group B member 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">RARA</name>
<name type="synonym">NR1B1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1987" name="Nature" volume="330" first="624" last="629">
<title>Identification of a receptor for the morphogen retinoic acid.</title>
<authorList>
<person name="Giguere V."/>
<person name="Ong E.S."/>
<person name="Segui P."/>
<person name="Evans R.M."/>
</authorList>
<dbReference type="PubMed" id="2825036"/>
<dbReference type="DOI" id="10.1038/330624a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1994" name="Proc. Natl. Acad. Sci. U.S.A." volume="91" first="1178" last="1182">
<title>PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors.</title>
<authorList>
<person name="Chen Z."/>
<person name="Guidez F."/>
<person name="Rousselot P."/>
<person name="Agadir A."/>
<person name="Chen S.-J."/>
<person name="Wang Z.-Y."/>
<person name="Degos L."/>
<person name="Zelent A."/>
<person name="Waxman S."/>
<person name="Chomienne C."/>
</authorList>
<dbReference type="PubMed" id="8302850"/>
<dbReference type="DOI" id="10.1073/pnas.91.3.1178"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-1)</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH PML</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1999" name="Mamm. Genome" volume="10" first="528" last="529">
<title>Genomic structure of the human retinoic acid receptor-alpha1 gene.</title>
<authorList>
<person name="Hjalt T.A.H."/>
<person name="Murray J.C."/>
</authorList>
<dbReference type="PubMed" id="10337631"/>
<dbReference type="DOI" id="10.1007/s003359901036"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM ALPHA-1)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2001" name="Nucleic Acids Res." volume="29" first="4901" last="4908">
<title>Retinoic acid receptor alpha1 variants, RARalpha1DeltaB and RARalpha1DeltaBC, define a new class of nuclear receptor isoforms.</title>
<authorList>
<person name="Parrado A."/>
<person name="Despouy G."/>
<person name="Kraiba R."/>
<person name="Le Pogam C."/>
<person name="Dupas S."/>
<person name="Choquette M."/>
<person name="Robledo M."/>
<person name="Larghero J."/>
<person name="Bui H."/>
<person name="Le Gall I."/>
<person name="Rochette-Egly C."/>
<person name="Chomienne C."/>
<person name="Padua R.A."/>
</authorList>
<dbReference type="PubMed" id="11812818"/>
<dbReference type="DOI" id="10.1093/nar/29.24.4901"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-1-DELTABC)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1045" last="1049">
<title>DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.</title>
<authorList>
<person name="Zody M.C."/>
<person name="Garber M."/>
<person name="Adams D.J."/>
<person name="Sharpe T."/>
<person name="Harrow J."/>
<person name="Lupski J.R."/>
<person name="Nicholson C."/>
<person name="Searle S.M."/>
<person name="Wilming L."/>
<person name="Young S.K."/>
<person name="Abouelleil A."/>
<person name="Allen N.R."/>
<person name="Bi W."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Bugalter B.E."/>
<person name="Butler J."/>
<person name="Chang J.L."/>
<person name="Chen C.-K."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="Cuomo C.A."/>
<person name="de Jong P.J."/>
<person name="DeCaprio D."/>
<person name="Dewar K."/>
<person name="FitzGerald M."/>
<person name="Gilbert J."/>
<person name="Gibson R."/>
<person name="Gnerre S."/>
<person name="Goldstein S."/>
<person name="Grafham D.V."/>
<person name="Grocock R."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hart E."/>
<person name="Norman C.H."/>
<person name="Humphray S."/>
<person name="Jaffe D.B."/>
<person name="Jones M."/>
<person name="Kamal M."/>
<person name="Khodiyar V.K."/>
<person name="LaButti K."/>
<person name="Laird G."/>
<person name="Lehoczky J."/>
<person name="Liu X."/>
<person name="Lokyitsang T."/>
<person name="Loveland J."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews L."/>
<person name="Mauceli E."/>
<person name="McCarroll S.A."/>
<person name="Mihalev A.H."/>
<person name="Mudge J."/>
<person name="Nguyen C."/>
<person name="Nicol R."/>
<person name="O'Leary S.B."/>
<person name="Osoegawa K."/>
<person name="Schwartz D.C."/>
<person name="Shaw-Smith C."/>
<person name="Stankiewicz P."/>
<person name="Steward C."/>
<person name="Swarbreck D."/>
<person name="Venkataraman V."/>
<person name="Whittaker C.A."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Bradley A."/>
<person name="Hubbard T."/>
<person name="Birren B.W."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Nusbaum C."/>
</authorList>
<dbReference type="PubMed" id="16625196"/>
<dbReference type="DOI" id="10.1038/nature04689"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS ALPHA-1 AND ALPHA-2)</scope>
<source>
<tissue>Blood</tissue>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1990" name="Nucleic Acids Res." volume="18" first="6799" last="6806">
<title>Characterization of a functional promoter for the human retinoic acid receptor-alpha (hRAR-alpha).</title>
<authorList>
<person name="Brand N.J."/>
<person name="Petkovich M."/>
<person name="Chambon P."/>
</authorList>
<dbReference type="PubMed" id="2175878"/>
<dbReference type="DOI" id="10.1093/nar/18.23.6799"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 1-80 (ISOFORM ALPHA-1)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1987" name="Nature" volume="330" first="444" last="450">
<title>A human retinoic acid receptor which belongs to the family of nuclear receptors.</title>
<authorList>
<person name="Petkovich M."/>
<person name="Brand N.J."/>
<person name="Krust A."/>
<person name="Chambon P."/>
</authorList>
<dbReference type="PubMed" id="2825025"/>
<dbReference type="DOI" id="10.1038/330444a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 31-462</scope>
</reference>
<reference key="9">
<citation type="submission" date="1988-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Chambon P."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1996" name="Blood" volume="87" first="882" last="886">
<title>The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion.</title>
<authorList>
<person name="Redner R.L."/>
<person name="Rush E.A."/>
<person name="Faas S."/>
<person name="Rudert W.A."/>
<person name="Corey S.J."/>
</authorList>
<dbReference type="PubMed" id="8562957"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 61-462</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH NPM</scope>
<source>
<tissue>Bone marrow</tissue>
</source>
</reference>
<reference key="11">
<citation type="submission" date="2000-06" db="EMBL/GenBank/DDBJ databases">
<title>Homo sapiens retinoic acid receptor alpha (RAR-alpha) gene, promoter and 5' region of RAR-alpha 2 isoform.</title>
<authorList>
<person name="Chen A."/>
<person name="Petrie K."/>
<person name="Waxman S."/>
<person name="Zelent A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-54 (ISOFORM ALPHA-2)</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="Leuk. Lymphoma" volume="44" first="111" last="115">
<title>Cytogenetics, FISH and RT-PCR analysis of acute promyelocytic leukemia: structure of the fusion point in a case lacking classic t(15;17) translocation.</title>
<authorList>
<person name="Fujita K."/>
<person name="Oba R."/>
<person name="Harada H."/>
<person name="Mori H."/>
<person name="Niikura H."/>
<person name="Isoyama K."/>
<person name="Omine M."/>
</authorList>
<dbReference type="PubMed" id="12691149"/>
<dbReference type="DOI" id="10.1080/1042819021000040305"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 61-68</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH PML</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1997" name="Cell" volume="90" first="569" last="580">
<title>Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300.</title>
<authorList>
<person name="Chen H."/>
<person name="Lin R.J."/>
<person name="Schiltz R.L."/>
<person name="Chakravarti D."/>
<person name="Nash A."/>
<person name="Nagy L."/>
<person name="Privalsky M.L."/>
<person name="Nakatani Y."/>
<person name="Evans R.M."/>
</authorList>
<dbReference type="PubMed" id="9267036"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)80516-4"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NCOA3</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="34283" last="34293">
<title>A nuclear factor ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo.</title>
<authorList>
<person name="Lee S.-K."/>
<person name="Anzick S.L."/>
<person name="Choi J.-E."/>
<person name="Bubendorf L."/>
<person name="Guan X.-Y."/>
<person name="Jung Y.-K."/>
<person name="Kallioniemi O.-P."/>
<person name="Kononen J."/>
<person name="Trent J.M."/>
<person name="Azorsa D."/>
<person name="Jhun B.-H."/>
<person name="Cheong J.H."/>
<person name="Lee Y.C."/>
<person name="Meltzer P.S."/>
<person name="Lee J.W."/>
</authorList>
<dbReference type="PubMed" id="10567404"/>
<dbReference type="DOI" id="10.1074/jbc.274.48.34283"/>
</citation>
<scope>INTERACTION WITH NCOA6</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="28624" last="28630">
<title>Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha.</title>
<authorList>
<person name="Qi C."/>
<person name="Chang J."/>
<person name="Zhu Y."/>
<person name="Yeldandi A.V."/>
<person name="Rao S.M."/>
<person name="Zhu Y.-J."/>
</authorList>
<dbReference type="PubMed" id="12039952"/>
<dbReference type="DOI" id="10.1074/jbc.m201053200"/>
</citation>
<scope>INTERACTION WITH PRMT2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="3358" last="3372">
<title>ERAP140, a conserved tissue-specific nuclear receptor coactivator.</title>
<authorList>
<person name="Shao W."/>
<person name="Halachmi S."/>
<person name="Brown M."/>
</authorList>
<dbReference type="PubMed" id="11971969"/>
<dbReference type="DOI" id="10.1128/mcb.22.10.3358-3372.2002"/>
</citation>
<scope>INTERACTION WITH NCOA7</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="9705" last="9725">
<title>Retinoid X receptor regulates Nur77/TR3-dependent apoptosis [corrected] by modulating its nuclear export and mitochondrial targeting.</title>
<authorList>
<person name="Cao X."/>
<person name="Liu W."/>
<person name="Lin F."/>
<person name="Li H."/>
<person name="Kolluri S.K."/>
<person name="Lin B."/>
<person name="Han Y.H."/>
<person name="Dawson M.I."/>
<person name="Zhang X.K."/>
</authorList>
<dbReference type="PubMed" id="15509776"/>
<dbReference type="DOI" id="10.1128/mcb.24.22.9705-9725.2004"/>
</citation>
<scope>INTERACTION WITH RXRA</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="330" first="746" last="754">
<title>Requirement of the coiled-coil domain of PML-RARalpha oncoprotein for localization, sumoylation, and inhibition of monocyte differentiation.</title>
<authorList>
<person name="Kim Y.E."/>
<person name="Kim D.Y."/>
<person name="Lee J.M."/>
<person name="Kim S.T."/>
<person name="Han T.H."/>
<person name="Ahn J.H."/>
</authorList>
<dbReference type="PubMed" id="15809060"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2005.03.052"/>
</citation>
<scope>INTERACTION OF THE PML-RARALPHA ONCOPROTEIN WITH UBE2I</scope>
<scope>SUMOYLATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="Cell" volume="122" first="835" last="847">
<title>The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling.</title>
<authorList>
<person name="Epping M.T."/>
<person name="Wang L."/>
<person name="Edel M.J."/>
<person name="Carlee L."/>
<person name="Hernandez M."/>
<person name="Bernards R."/>
</authorList>
<dbReference type="PubMed" id="16179254"/>
<dbReference type="DOI" id="10.1016/j.cell.2005.07.003"/>
</citation>
<scope>INTERACTION WITH PRAME</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="Biochem. J." volume="395" first="653" last="662">
<title>Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha.</title>
<authorList>
<person name="Srinivas H."/>
<person name="Xia D."/>
<person name="Moore N.L."/>
<person name="Uray I.P."/>
<person name="Kim H."/>
<person name="Ma L."/>
<person name="Weigel N.L."/>
<person name="Brown P.H."/>
<person name="Kurie J.M."/>
</authorList>
<dbReference type="PubMed" id="16417524"/>
<dbReference type="DOI" id="10.1042/bj20051794"/>
</citation>
<scope>PHOSPHORYLATION AT SER-96</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH AKT1</scope>
<scope>MUTAGENESIS OF SER-95; SER-96; SER-154 AND SER-157</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="17588" last="17598">
<title>Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor.</title>
<authorList>
<person name="Cho Y.S."/>
<person name="Kim E.J."/>
<person name="Park U.H."/>
<person name="Sin H.S."/>
<person name="Um S.J."/>
</authorList>
<dbReference type="PubMed" id="16606617"/>
<dbReference type="DOI" id="10.1074/jbc.m512616200"/>
</citation>
<scope>INTERACTION WITH ASXL1 AND NCOA1</scope>
<scope>MUTAGENESIS OF 409-ILE-LEU-410; GLU-412; 413-MET-LEU-414 AND GLU-415</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2007" name="J. Cell. Biochem." volume="102" first="1021" last="1035">
<title>RIF-1, a novel nuclear receptor corepressor that associates with the nuclear matrix.</title>
<authorList>
<person name="Li H.J."/>
<person name="Haque Z.K."/>
<person name="Chen A."/>
<person name="Mendelsohn M."/>
</authorList>
<dbReference type="PubMed" id="17455211"/>
<dbReference type="DOI" id="10.1002/jcb.21340"/>
</citation>
<scope>INTERACTION WITH LRIF1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Endocrinology" volume="150" first="5586" last="5595">
<title>Small ubiquitin-like modifier-2 modification of retinoic acid receptor-alpha regulates its subcellular localization and transcriptional activity.</title>
<authorList>
<person name="Zhu L."/>
<person name="Santos N.C."/>
<person name="Kim K.H."/>
</authorList>
<dbReference type="PubMed" id="19850744"/>
<dbReference type="DOI" id="10.1210/en.2009-0868"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUMOYLATION AT LYS-166; LYS-171 AND LYS-399</scope>
<scope>MUTAGENESIS OF LYS-147; LYS-166; LYS-171 AND LYS-399</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Nature" volume="459" first="455" last="459">
<title>GlcNAcylation of a histone methyltransferase in retinoic-acid-induced granulopoiesis.</title>
<authorList>
<person name="Fujiki R."/>
<person name="Chikanishi T."/>
<person name="Hashiba W."/>
<person name="Ito H."/>
<person name="Takada I."/>
<person name="Roeder R.G."/>
<person name="Kitagawa H."/>
<person name="Kato S."/>
</authorList>
<dbReference type="PubMed" id="19377461"/>
<dbReference type="DOI" id="10.1038/nature07954"/>
</citation>
<scope>CAUTION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="BMC Mol. Biol." volume="11" first="3" last="3">
<title>The transforming acidic coiled coil (TACC1) protein modulates the transcriptional activity of the nuclear receptors TR and RAR.</title>
<authorList>
<person name="Guyot R."/>
<person name="Vincent S."/>
<person name="Bertin J."/>
<person name="Samarut J."/>
<person name="Ravel-Chapuis P."/>
</authorList>
<dbReference type="PubMed" id="20078863"/>
<dbReference type="DOI" id="10.1186/1471-2199-11-3"/>
</citation>
<scope>INTERACTION WITH TACC1</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="Nature" volume="505" first="574" last="574">
<title>Retraction: GlcNAcylation of a histone methyltransferase in retinoic-acid-induced granulopoiesis.</title>
<authorList>
<person name="Fujiki R."/>
<person name="Chikanishi T."/>
<person name="Hashiba W."/>
<person name="Ito H."/>
<person name="Takada I."/>
<person name="Roeder R.G."/>
<person name="Kitagawa H."/>
<person name="Kato S."/>
</authorList>
<dbReference type="PubMed" id="24336203"/>
<dbReference type="DOI" id="10.1038/nature12896"/>
</citation>
<scope>CAUTION</scope>
<scope>RETRACTION NOTICE OF PUBMED:20078863</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="Endocrinology" volume="151" first="2361" last="2372">
<title>Activity of retinoic acid receptor-alpha is directly regulated at its protein kinase A sites in response to follicle-stimulating hormone signaling.</title>
<authorList>
<person name="Santos N.C."/>
<person name="Kim K.H."/>
</authorList>
<dbReference type="PubMed" id="20215566"/>
<dbReference type="DOI" id="10.1210/en.2009-1338"/>
</citation>
<scope>PHOSPHORYLATION AT SER-219 AND SER-369</scope>
<scope>INTERACTION WITH RXRA AND PRKAR1A</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF SER-219 AND SER-369</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="12027" last="12035">
<title>Familial focal segmental glomerulosclerosis (FSGS)-linked alpha-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors.</title>
<authorList>
<person name="Khurana S."/>
<person name="Chakraborty S."/>
<person name="Lam M."/>
<person name="Liu Y."/>
<person name="Su Y.T."/>
<person name="Zhao X."/>
<person name="Saleem M.A."/>
<person name="Mathieson P.W."/>
<person name="Bruggeman L.A."/>
<person name="Kao H.Y."/>
</authorList>
<dbReference type="PubMed" id="22351778"/>
<dbReference type="DOI" id="10.1074/jbc.m112.345421"/>
</citation>
<scope>INTERACTION WITH ACTN4</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2015" name="Brain" volume="138" first="3581" last="3597">
<title>Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination.</title>
<authorList>
<person name="Natrajan M.S."/>
<person name="de la Fuente A.G."/>
<person name="Crawford A.H."/>
<person name="Linehan E."/>
<person name="Nunez V."/>
<person name="Johnson K.R."/>
<person name="Wu T."/>
<person name="Fitzgerald D.C."/>
<person name="Ricote M."/>
<person name="Bielekova B."/>
<person name="Franklin R.J."/>
</authorList>
<dbReference type="PubMed" id="26463675"/>
<dbReference type="DOI" id="10.1093/brain/awv289"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>REPRESSION BY AGING</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2017" name="Proc. Natl. Acad. Sci. U.S.A." volume="114" first="2072" last="2077">
<title>MicroRNA-10a is crucial for endothelial response to different flow patterns via interaction of retinoid acid receptors and histone deacetylases.</title>
<authorList>
<person name="Lee D.Y."/>
<person name="Lin T.E."/>
<person name="Lee C.I."/>
<person name="Zhou J."/>
<person name="Huang Y.H."/>
<person name="Lee P.L."/>
<person name="Shih Y.T."/>
<person name="Chien S."/>
<person name="Chiu J.J."/>
</authorList>
<dbReference type="PubMed" id="28167758"/>
<dbReference type="DOI" id="10.1073/pnas.1621425114"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RXRA; RXRG; HDAC3; HDAC5 AND HDAC7</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION BY PULSATILE SHEAR STRESS</scope>
<scope>ACETYLATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2019" name="J. Steroid Biochem. Mol. Biol." volume="187" first="118" last="123">
<title>Nuclear hormone receptors: Ancient 9aaTAD and evolutionally gained NCoA activation pathways.</title>
<authorList>
<person name="Piskacek M."/>
<person name="Havelka M."/>
<person name="Jendruchova K."/>
<person name="Knight A."/>
</authorList>
<dbReference type="PubMed" id="30468856"/>
<dbReference type="DOI" id="10.1016/j.jsbmb.2018.11.008"/>
</citation>
<scope>9AATAD MOTIF</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2000" name="EMBO J." volume="19" first="1045" last="1054">
<title>Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1.</title>
<authorList>
<person name="Rastinejad F."/>
<person name="Wagner T."/>
<person name="Zhao Q."/>
<person name="Khorasanizadeh S."/>
</authorList>
<dbReference type="PubMed" id="10698945"/>
<dbReference type="DOI" id="10.1093/emboj/19.5.1045"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 82-167 IN COMPLEX WITH RXRA AND DNA</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2000" name="Mol. Cell" volume="5" first="289" last="298">
<title>Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains.</title>
<authorList>
<person name="Bourguet W."/>
<person name="Vivat V."/>
<person name="Wurtz J.M."/>
<person name="Chambon P."/>
<person name="Gronemeyer H."/>
<person name="Moras D."/>
</authorList>
<dbReference type="PubMed" id="10882070"/>
<dbReference type="DOI" id="10.1016/s1097-2765(00)80424-4"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 182-416 IN COMPLEX WITH M.MUSCULUS RXRA</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2010" name="Nat. Struct. Mol. Biol." volume="17" first="801" last="807">
<title>A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor.</title>
<authorList>
<person name="le Maire A."/>
<person name="Teyssier C."/>
<person name="Erb C."/>
<person name="Grimaldi M."/>
<person name="Alvarez S."/>
<person name="de Lera A.R."/>
<person name="Balaguer P."/>
<person name="Gronemeyer H."/>
<person name="Royer C.A."/>
<person name="Germain P."/>
<person name="Bourguet W."/>
</authorList>
<dbReference type="PubMed" id="20543827"/>
<dbReference type="DOI" id="10.1038/nsmb.1855"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 176-421 IN COMPLEXES WITH AGONIST AM580 AND NCOA1 AND WITH INVERSE AGONIST BMS493 AND NCOR1</scope>
<scope>INTERACTION WITH NCOR1 AND NCOR2</scope>
<scope>MUTAGENESIS OF ILE-396</scope>
</reference>
<comment type="function">
<text evidence="5 17 21 23 28 32">Receptor for retinoic acid (PubMed:19850744, PubMed:16417524, PubMed:20215566). Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes (PubMed:28167758). The RXR/RAR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5 (PubMed:28167758). In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone deacetylation, chromatin condensation and transcriptional suppression (PubMed:16417524). On ligand binding, the corepressors dissociate from the receptors and associate with the coactivators leading to transcriptional activation (PubMed:9267036, PubMed:19850744, PubMed:20215566). Formation of a complex with histone deacetylases might lead to inhibition of RARE DNA element binding and to transcriptional repression (PubMed:28167758). Transcriptional activation and RARE DNA element binding might be supported by the transcription factor KLF2 (PubMed:28167758). RARA plays an essential role in the regulation of retinoic acid-induced germ cell development during spermatogenesis (By similarity). Has a role in the survival of early spermatocytes at the beginning prophase of meiosis (By similarity). In Sertoli cells, may promote the survival and development of early meiotic prophase spermatocytes (By similarity). In concert with RARG, required for skeletal growth, matrix homeostasis and growth plate function (By similarity). Together with RXRA, positively regulates microRNA-10a expression, thereby inhibiting the GATA6/VCAM1 signaling response to pulsatile shear stress in vascular endothelial cells (PubMed:28167758). In association with HDAC3, HDAC5 and HDAC7 corepressors, plays a role in the repression of microRNA-10a and thereby promotes the inflammatory response (PubMed:28167758).</text>
</comment>
<comment type="subunit">
<text evidence="5 8 9 10 11 12 14 16 17 18 19 22 23 24 25 28 29 32">Heterodimer; with RXRA (via C-terminus); association with RXRA is enhanced by pulsatile shear stress (PubMed:28167758, PubMed:10698945, PubMed:10882070, PubMed:20215566, PubMed:15509776). Binds DNA preferentially as a heterodimer (PubMed:10698945, PubMed:28167758). RXRA serves as enhancer to induce RARA binding to RARE (PubMed:30468856). Interacts with RXRG (PubMed:28167758). Interacts with coactivators NCOA3 and NCOA6 (PubMed:9267036, PubMed:10567404). Interacts with NCOA7; the interaction requires ligand-binding (PubMed:11971969). Interacts (via the ligand-binding domain) with PRAME; the interaction is ligand (retinoic acid)-dependent (PubMed:16179254). Interacts with AKT1; the interaction phosphorylates RARA and represses transactivation (PubMed:16417524). Interacts with PRKAR1A; the interaction negatively regulates RARA transcriptional activity (PubMed:20215566). Interacts with NCOR1 and NCOR2 (PubMed:20543827). Interacts with PRMT2 (PubMed:12039952). Interacts with LRIF1 (PubMed:17455211). Interacts with ASXL1 and NCOA1 (PubMed:16606617). Interacts with ACTN4 (PubMed:22351778). In a complex with HDAC3, HDAC5 and HDAC7; the HDACs serve as corepressors of RARA, causing its deacetylation and inhibition of RARE DNA element binding; association with HDAC3, HDAC5 and HDAC7 is increased upon oscillatory shear stress (PubMed:28167758). Interacts with CDK7 (By similarity). In the absence of hormonal ligand, interacts with TACC1 (PubMed:20078863).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-15971664">
<id>O43707-1</id>
<label>ACTN4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-12150557">
<id>O15296</id>
<label>ALOX15B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-750671">
<id>Q15699</id>
<label>ALX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-1805814">
<id>Q96RK4</id>
<label>BBS4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-748961">
<id>O95273</id>
<label>CCNDBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-741406">
<id>P51946</id>
<label>CCNH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-530054">
<id>Q15910</id>
<label>EZH2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-3909604">
<id>P50148</id>
<label>GNAQ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-5659717">
<id>Q9UKP3</id>
<label>ITGB1BP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-348259">
<id>Q96EZ8</id>
<label>MCRS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-394459">
<id>Q15648</id>
<label>MED1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-394558">
<id>Q71SY5</id>
<label>MED25</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-455189">
<id>Q15788</id>
<label>NCOA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-81196">
<id>Q9Y6Q9</id>
<label>NCOA3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-347233">
<id>O75376</id>
<label>NCOR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-80830">
<id>Q9Y618</id>
<label>NCOR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-2007911">
<id>Q16236</id>
<label>NFE2L2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-18764867">
<id>P13056-2</id>
<label>NR2C1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-746484">
<id>P48552</id>
<label>NRIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-6601215">
<id>Q9UPP1-2</id>
<label>PHF8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-742388">
<id>Q9H8W4</id>
<label>PLEKHF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-781384">
<id>P37231</id>
<label>PPARG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-352053">
<id>P78527</id>
<label>PRKDC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-78598">
<id>P19793</id>
<label>RXRA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-748576">
<id>P28702</id>
<label>RXRB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-16429492">
<id>P28702-3</id>
<label>RXRB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-712405">
<id>P48443</id>
<label>RXRG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>17</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
<label>SIRT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-80140">
<id>P63165</id>
<label>SUMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-750487">
<id>Q8WW24</id>
<label>TEKT4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-950016">
<id>Q2M1K9</id>
<label>ZNF423</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-1565930">
<id>Q91XC0</id>
<label>Ajuba</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-413374">
<id>P10276</id>
</interactant>
<interactant intactId="EBI-5743705">
<id>P59598</id>
<label>Asxl1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10197061">
<id>P10276-2</id>
</interactant>
<interactant intactId="EBI-746484">
<id>P48552</id>
<label>NRIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10197061">
<id>P10276-2</id>
</interactant>
<interactant intactId="EBI-748576">
<id>P28702</id>
<label>RXRB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10197061">
<id>P10276-2</id>
</interactant>
<interactant intactId="EBI-712405">
<id>P48443</id>
<label>RXRG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10197061">
<id>P10276-2</id>
</interactant>
<interactant intactId="EBI-750487">
<id>Q8WW24</id>
<label>TEKT4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="21 28">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="21 28">Cytoplasm</location>
</subcellularLocation>
<text evidence="5 21 28">Nuclear localization depends on ligand binding, phosphorylation and sumoylation (PubMed:19850744). Translocation to the nucleus in the absence of ligand is dependent on activation of PKC and the downstream MAPK phosphorylation (By similarity). Increased nuclear localization upon pulsatile shear stress (PubMed:28167758).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P10276-1</id>
<name>Alpha-1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P10276-2</id>
<name>Alpha-2</name>
<sequence type="described" ref="VSP_003629"/>
</isoform>
<isoform>
<id>P10276-3</id>
<name>Alpha-1-deltaBC</name>
<sequence type="described" ref="VSP_043143"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="27">Expressed in monocytes.</text>
</comment>
<comment type="induction">
<text evidence="27 28">Down-regulated by aging (PubMed:26463675). Induced by pulsatile shear stress (PubMed:28167758).</text>
</comment>
<comment type="domain">
<text>Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain.</text>
</comment>
<comment type="domain">
<text evidence="36">The 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors.</text>
</comment>
<comment type="PTM">
<text evidence="4 17 23">Phosphorylated on serine and threonine residues. Phosphorylation does not change during cell cycle. Phosphorylation on Ser-77 is crucial for transcriptional activity (By similarity). Phosphorylation by AKT1 is required for the repressor activity but has no effect on DNA binding, protein stability nor subcellular localization. Phosphorylated by PKA in vitro. This phosphorylation on Ser-219 and Ser-369 is critical for ligand binding, nuclear localization and transcriptional activity in response to FSH signaling.</text>
</comment>
<comment type="PTM">
<text evidence="15 21">Sumoylated with SUMO2, mainly on Lys-399 which is also required for SENP6 binding. On all-trans retinoic acid (ATRA) binding, a confromational change may occur that allows sumoylation on two additional site, Lys-166 and Lys-171. Probably desumoylated by SENP6. Sumoylation levels determine nuclear localization and regulate ATRA-mediated transcriptional activity.</text>
</comment>
<comment type="PTM">
<text>Trimethylation enhances heterodimerization with RXRA and positively modulates the transcriptional activation.</text>
</comment>
<comment type="PTM">
<text>Ubiquitinated.</text>
</comment>
<comment type="PTM">
<text evidence="28">Acetylated; acetylation is increased upon pulsatile shear stress and decreased upon oscillatory shear stress.</text>
</comment>
<comment type="disease">
<text evidence="13 30 31">Chromosomal aberrations involving RARA are commonly found in acute promyelocytic leukemia. Translocation t(11;17)(q32;q21) with ZBTB16/PLZF; translocation t(15;17)(q21;q21) with PML; translocation t(5;17)(q32;q11) with NPM. The PML-RARA oncoprotein requires both the PML ring structure and coiled-coil domain for both interaction with UBE2I, nuclear microspeckle location and sumoylation. In addition, the coiled-coil domain functions in blocking RA-mediated transactivation and cell differentiation.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform Alpha-1-deltaBC</molecule>
<text evidence="35">Does not bind nor transactivate RARE on its own but may do so as a heterodimer with Alpha-1.</text>
</comment>
<comment type="similarity">
<text evidence="35">Belongs to the nuclear hormone receptor family. NR1 subfamily.</text>
</comment>
<comment type="caution">
<text evidence="20 26">Was originally thought to be part of the MLL5-L complex, at least composed of KMT2E, STK38, PPP1CA, PPP1CB, PPP1CC, HCFC1, ACTB and OGT (PubMed:19377461). However, the corresponding article has been retracted (PubMed:24336203).</text>
</comment>
<comment type="sequence caution" evidence="35">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAB00112" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="35">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAB00113" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="35">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAB62809" version="1"/>
</conflict>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/RARAID46.html"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Retinoic_acid_receptor"/>
<text>Retinoic acid receptor entry</text>
</comment>
<dbReference type="EMBL" id="X06614">
<property type="protein sequence ID" value="CAA29829.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X06538">
<property type="protein sequence ID" value="CAA29787.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF088895">
<property type="protein sequence ID" value="AAD05222.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF088889">
<property type="protein sequence ID" value="AAD05222.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF088890">
<property type="protein sequence ID" value="AAD05222.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF088891">
<property type="protein sequence ID" value="AAD05222.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF088892">
<property type="protein sequence ID" value="AAD05222.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF088893">
<property type="protein sequence ID" value="AAD05222.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF088894">
<property type="protein sequence ID" value="AAD05222.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="FJ487576">
<property type="protein sequence ID" value="ACK86665.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC080112">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC008727">
<property type="protein sequence ID" value="AAH08727.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC071733">
<property type="protein sequence ID" value="AAH71733.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X56058">
<property type="protein sequence ID" value="CAA39533.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X58685">
<property type="protein sequence ID" value="CAA39533.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X58685">
<property type="protein sequence ID" value="CAA41532.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U41742">
<property type="protein sequence ID" value="AAB00112.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U41743">
<property type="protein sequence ID" value="AAB00113.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283809">
<property type="protein sequence ID" value="AAF87249.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB067754">
<property type="protein sequence ID" value="BAB62809.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11366.1">
<molecule id="P10276-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS42317.1">
<molecule id="P10276-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45671.1">
<molecule id="P10276-3"/>
</dbReference>
<dbReference type="PIR" id="A29491">
<property type="entry name" value="A29491"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000955.1">
<molecule id="P10276-1"/>
<property type="nucleotide sequence ID" value="NM_000964.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001019980.1">
<molecule id="P10276-2"/>
<property type="nucleotide sequence ID" value="NM_001024809.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001138773.1">
<molecule id="P10276-1"/>
<property type="nucleotide sequence ID" value="NM_001145301.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001138774.1">
<molecule id="P10276-3"/>
<property type="nucleotide sequence ID" value="NM_001145302.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005257610.1">
<molecule id="P10276-1"/>
<property type="nucleotide sequence ID" value="XM_005257553.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005257611.1">
<molecule id="P10276-1"/>
<property type="nucleotide sequence ID" value="XM_005257554.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011523397.1">
<molecule id="P10276-1"/>
<property type="nucleotide sequence ID" value="XM_011525095.1"/>
</dbReference>
<dbReference type="PDB" id="1DKF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="B=182-416"/>
</dbReference>
<dbReference type="PDB" id="1DSZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=82-167"/>
</dbReference>
<dbReference type="PDB" id="3A9E">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="B=153-421"/>
</dbReference>
<dbReference type="PDB" id="3KMR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=176-421"/>
</dbReference>
<dbReference type="PDB" id="3KMZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=176-421"/>
</dbReference>
<dbReference type="PDB" id="4DQM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A/C=182-415"/>
</dbReference>
<dbReference type="PDB" id="5K13">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=181-426"/>
</dbReference>
<dbReference type="PDBsum" id="1DKF"/>
<dbReference type="PDBsum" id="1DSZ"/>
<dbReference type="PDBsum" id="3A9E"/>
<dbReference type="PDBsum" id="3KMR"/>
<dbReference type="PDBsum" id="3KMZ"/>
<dbReference type="PDBsum" id="4DQM"/>
<dbReference type="PDBsum" id="5K13"/>
<dbReference type="SASBDB" id="P10276"/>
<dbReference type="SMR" id="P10276"/>
<dbReference type="BioGRID" id="111849">
<property type="interactions" value="157"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-508">
<property type="entry name" value="RXRalpha-RARalpha retinoic acid receptor complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-525">
<property type="entry name" value="RARalpha-NCOA1 activated retinoic acid receptor complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-666">
<property type="entry name" value="RARalpha-NCOA2 activated retinoic acid receptor complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-816">
<property type="entry name" value="RXRalpha-RARalpha-NCOA2 retinoic acid receptor complex"/>
</dbReference>
<dbReference type="CORUM" id="P10276"/>
<dbReference type="DIP" id="DIP-34N"/>
<dbReference type="IntAct" id="P10276">
<property type="interactions" value="71"/>
</dbReference>
<dbReference type="MINT" id="P10276"/>
<dbReference type="STRING" id="9606.ENSP00000254066"/>
<dbReference type="BindingDB" id="P10276"/>
<dbReference type="ChEMBL" id="CHEMBL2055"/>
<dbReference type="DrugBank" id="DB00459">
<property type="generic name" value="Acitretin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00210">
<property type="generic name" value="Adapalene"/>
</dbReference>
<dbReference type="DrugBank" id="DB00523">
<property type="generic name" value="Alitretinoin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00926">
<property type="generic name" value="Etretinate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00982">
<property type="generic name" value="Isotretinoin"/>
</dbReference>
<dbReference type="DrugBank" id="DB05785">
<property type="generic name" value="LGD-1550"/>
</dbReference>
<dbReference type="DrugBank" id="DB04942">
<property type="generic name" value="Tamibarotene"/>
</dbReference>
<dbReference type="DrugBank" id="DB00799">
<property type="generic name" value="Tazarotene"/>
</dbReference>
<dbReference type="DrugBank" id="DB00755">
<property type="generic name" value="Tretinoin"/>
</dbReference>
<dbReference type="DrugBank" id="DB12808">
<property type="generic name" value="Trifarotene"/>
</dbReference>
<dbReference type="DrugCentral" id="P10276"/>
<dbReference type="GuidetoPHARMACOLOGY" id="590"/>
<dbReference type="MoonDB" id="P10276">
<property type="type" value="Predicted"/>
</dbReference>
<dbReference type="iPTMnet" id="P10276"/>
<dbReference type="PhosphoSitePlus" id="P10276"/>
<dbReference type="SwissPalm" id="P10276"/>
<dbReference type="BioMuta" id="RARA"/>
<dbReference type="DMDM" id="133483"/>
<dbReference type="jPOST" id="P10276"/>
<dbReference type="MassIVE" id="P10276"/>
<dbReference type="PaxDb" id="P10276"/>
<dbReference type="PeptideAtlas" id="P10276"/>
<dbReference type="PRIDE" id="P10276"/>
<dbReference type="ProteomicsDB" id="52592">
<molecule id="P10276-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52593">
<molecule id="P10276-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52594">
<molecule id="P10276-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="16473">
<property type="antibodies" value="762 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="5914"/>
<dbReference type="Ensembl" id="ENST00000254066">
<molecule id="P10276-1"/>
<property type="protein sequence ID" value="ENSP00000254066"/>
<property type="gene ID" value="ENSG00000131759"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000394081">
<molecule id="P10276-2"/>
<property type="protein sequence ID" value="ENSP00000377643"/>
<property type="gene ID" value="ENSG00000131759"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000394089">
<molecule id="P10276-1"/>
<property type="protein sequence ID" value="ENSP00000377649"/>
<property type="gene ID" value="ENSG00000131759"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000425707">
<molecule id="P10276-3"/>
<property type="protein sequence ID" value="ENSP00000389993"/>
<property type="gene ID" value="ENSG00000131759"/>
</dbReference>
<dbReference type="GeneID" id="5914"/>
<dbReference type="KEGG" id="hsa:5914"/>
<dbReference type="UCSC" id="uc002hun.3">
<molecule id="P10276-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5914"/>
<dbReference type="DisGeNET" id="5914"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000131759.17"/>
<dbReference type="GeneCards" id="RARA"/>
<dbReference type="HGNC" id="HGNC:9864">
<property type="gene designation" value="RARA"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000131759">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="RARA"/>
<dbReference type="MIM" id="180240">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="612376">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P10276"/>
<dbReference type="OpenTargets" id="ENSG00000131759"/>
<dbReference type="Orphanet" id="520">
<property type="disease" value="Acute promyelocytic leukemia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA34225"/>
<dbReference type="eggNOG" id="KOG3575">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000159997"/>
<dbReference type="HOGENOM" id="CLU_007368_18_2_1"/>
<dbReference type="InParanoid" id="P10276"/>
<dbReference type="KO" id="K08527"/>
<dbReference type="OMA" id="AECSESY"/>
<dbReference type="OrthoDB" id="1165737at2759"/>
<dbReference type="PhylomeDB" id="P10276"/>
<dbReference type="TreeFam" id="TF328382"/>
<dbReference type="PathwayCommons" id="P10276"/>
<dbReference type="Reactome" id="R-HSA-383280">
<property type="pathway name" value="Nuclear Receptor transcription pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4090294">
<property type="pathway name" value="SUMOylation of intracellular receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5362517">
<property type="pathway name" value="Signaling by Retinoic Acid"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5617472">
<property type="pathway name" value="Activation of anterior HOX genes in hindbrain development during early embryogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9616222">
<property type="pathway name" value="Transcriptional regulation of granulopoiesis"/>
</dbReference>
<dbReference type="SignaLink" id="P10276"/>
<dbReference type="SIGNOR" id="P10276"/>
<dbReference type="BioGRID-ORCS" id="5914">
<property type="hits" value="15 hits in 898 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="RARA">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P10276"/>
<dbReference type="GeneWiki" id="Retinoic_acid_receptor_alpha"/>
<dbReference type="GenomeRNAi" id="5914"/>
<dbReference type="Pharos" id="P10276">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P10276"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="RNAct" id="P10276">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000131759">
<property type="expression patterns" value="Expressed in nasal cavity epithelium and 232 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P10276">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P10276">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0015629">
<property type="term" value="C:actin cytoskeleton"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0030425">
<property type="term" value="C:dendrite"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090575">
<property type="term" value="C:RNA polymerase II transcription regulator complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051393">
<property type="term" value="F:alpha-actinin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031490">
<property type="term" value="F:chromatin DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0008144">
<property type="term" value="F:drug binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048027">
<property type="term" value="F:mRNA 5'-UTR binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004879">
<property type="term" value="F:nuclear receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019904">
<property type="term" value="F:protein domain specific binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051018">
<property type="term" value="F:protein kinase A binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043422">
<property type="term" value="F:protein kinase B binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001972">
<property type="term" value="F:retinoic acid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044323">
<property type="term" value="F:retinoic acid-responsive element binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990837">
<property type="term" value="F:sequence-specific double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:signaling receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000900">
<property type="term" value="F:translation repressor activity, mRNA regulatory element binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0043277">
<property type="term" value="P:apoptotic cell clearance"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071391">
<property type="term" value="P:cellular response to estrogen stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071222">
<property type="term" value="P:cellular response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060591">
<property type="term" value="P:chondroblast differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031076">
<property type="term" value="P:embryonic camera-type eye development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060324">
<property type="term" value="P:face development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007565">
<property type="term" value="P:female pregnancy"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007281">
<property type="term" value="P:germ cell development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002068">
<property type="term" value="P:glandular epithelial cell development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003417">
<property type="term" value="P:growth plate cartilage development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0021766">
<property type="term" value="P:hippocampus development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009755">
<property type="term" value="P:hormone-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0060173">
<property type="term" value="P:limb development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001889">
<property type="term" value="P:liver development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035264">
<property type="term" value="P:multicellular organism growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0061037">
<property type="term" value="P:negative regulation of cartilage development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030853">
<property type="term" value="P:negative regulation of granulocyte differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032689">
<property type="term" value="P:negative regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032720">
<property type="term" value="P:negative regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001843">
<property type="term" value="P:neural tube closure"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003148">
<property type="term" value="P:outflow tract septum morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051099">
<property type="term" value="P:positive regulation of binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045787">
<property type="term" value="P:positive regulation of cell cycle"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032736">
<property type="term" value="P:positive regulation of interleukin-13 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032753">
<property type="term" value="P:positive regulation of interleukin-4 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032754">
<property type="term" value="P:positive regulation of interleukin-5 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045666">
<property type="term" value="P:positive regulation of neuron differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045630">
<property type="term" value="P:positive regulation of T-helper 2 cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030850">
<property type="term" value="P:prostate gland development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031641">
<property type="term" value="P:regulation of myelination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048167">
<property type="term" value="P:regulation of synaptic plasticity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034097">
<property type="term" value="P:response to cytokine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032355">
<property type="term" value="P:response to estradiol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045471">
<property type="term" value="P:response to ethanol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032526">
<property type="term" value="P:response to retinoic acid"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033189">
<property type="term" value="P:response to vitamin A"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048384">
<property type="term" value="P:retinoic acid receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060010">
<property type="term" value="P:Sertoli cell fate commitment"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007283">
<property type="term" value="P:spermatogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060534">
<property type="term" value="P:trachea cartilage development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0001657">
<property type="term" value="P:ureteric bud development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0055012">
<property type="term" value="P:ventricular cardiac muscle cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.565.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.50.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00365"/>
<dbReference type="InterPro" id="IPR035500">
<property type="entry name" value="NHR-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000536">
<property type="entry name" value="Nucl_hrmn_rcpt_lig-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR001723">
<property type="entry name" value="Nuclear_hrmn_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003078">
<property type="entry name" value="Retinoic_acid_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR001628">
<property type="entry name" value="Znf_hrmn_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR013088">
<property type="entry name" value="Znf_NHR/GATA"/>
</dbReference>
<dbReference type="Pfam" id="PF00104">
<property type="entry name" value="Hormone_recep"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00105">
<property type="entry name" value="zf-C4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01292">
<property type="entry name" value="RETNOICACIDR"/>
</dbReference>
<dbReference type="PRINTS" id="PR00398">
<property type="entry name" value="STRDHORMONER"/>
</dbReference>
<dbReference type="PRINTS" id="PR00047">
<property type="entry name" value="STROIDFINGER"/>
</dbReference>
<dbReference type="SMART" id="SM00430">
<property type="entry name" value="HOLI"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00399">
<property type="entry name" value="ZnF_C4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48508">
<property type="entry name" value="SSF48508"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51843">
<property type="entry name" value="NR_LBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00031">
<property type="entry name" value="NUCLEAR_REC_DBD_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51030">
<property type="entry name" value="NUCLEAR_REC_DBD_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Retinoic acid receptor alpha" id="PRO_0000053461">
<location>
<begin position="1"/>
<end position="462"/>
</location>
</feature>
<feature type="domain" description="NR LBD" evidence="7">
<location>
<begin position="183"/>
<end position="417"/>
</location>
</feature>
<feature type="DNA-binding region" description="Nuclear receptor" evidence="6">
<location>
<begin position="88"/>
<end position="153"/>
</location>
</feature>
<feature type="zinc finger region" description="NR C4-type" evidence="6">
<location>
<begin position="88"/>
<end position="108"/>
</location>
</feature>
<feature type="zinc finger region" description="NR C4-type" evidence="6">
<location>
<begin position="124"/>
<end position="148"/>
</location>
</feature>
<feature type="region of interest" description="Modulating">
<location>
<begin position="1"/>
<end position="87"/>
</location>
</feature>
<feature type="region of interest" description="Hinge">
<location>
<begin position="154"/>
<end position="182"/>
</location>
</feature>
<feature type="region of interest" description="Required for binding corepressor NCOR1">
<location>
<begin position="404"/>
<end position="419"/>
</location>
</feature>
<feature type="short sequence motif" description="9aaTAD" evidence="29">
<location>
<begin position="408"/>
<end position="416"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form PLZF-RAR-alpha, RAR-alpha1-PLZF and PML-RAR-alpha oncogenes">
<location>
<begin position="60"/>
<end position="61"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK7" evidence="5">
<location>
<position position="77"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKB/AKT1" evidence="17">
<location>
<position position="96"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKA" evidence="23">
<location>
<position position="219"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKA" evidence="23">
<location>
<position position="369"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="21">
<location>
<position position="166"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="21">
<location>
<position position="171"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="21">
<location>
<position position="399"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Alpha-2." id="VSP_003629" evidence="34">
<original>MASNSSSCPTPGGGHLNGYPVPPYAFFFPPMLGGLSPPGALTTLQHQLPVSGYSTPSPAT</original>
<variation>MYESVEVGGPTPNPFLVVDFYNQNRACLLPEKGLPAPGPYSTPLRTPLWNGSNHS</variation>
<location>
<begin position="1"/>
<end position="60"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Alpha-1-deltaBC." id="VSP_043143" evidence="33">
<location>
<begin position="61"/>
<end position="157"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on PKB/AKT1-mediated phosphorylation. Repressed transactivation." evidence="17">
<original>S</original>
<variation>A</variation>
<location>
<position position="95"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes PKB/AKT1-mediated phosphorylation. Repressed transactivation." evidence="17">
<original>S</original>
<variation>A</variation>
<location>
<position position="96"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates sumoylation in the presence or absence of ATRA and primarily nuclear localization and enhanced ATRA-mediated transcriptional activity; when associated with R-166; R-171 and R-399." evidence="21">
<original>K</original>
<variation>R</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on PKB/AKT1-mediated phosphorylation. No repression of transactivation." evidence="17">
<original>S</original>
<variation>A</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on PKB/AKT1-mediated phosphorylation. Repressed transactivation." evidence="17">
<original>S</original>
<variation>A</variation>
<location>
<position position="157"/>
</location>
</feature>
<feature type="mutagenesis site" description="Cytoplasmic in the absence of ATRA and reduced transcriptional activity in the presence of ATRA. Low sumoylation levels in the presence of ATRA; when associated with R-399. Nuclear localization and enhanced transcriptional activity; when associated with R-171 and R-399. Primarily nuclear localization and enhanced ATRA-mediated transcriptional activity; when associated with R-147; R-171 and R-399." evidence="21">
<original>K</original>
<variation>R</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="mutagenesis site" description="Cytoplasmic in the absence of ATRA and reduced transcriptional activity in the presence of ATRA. Low sumoylation levels in the presence of ATRA; when associated with R-399. Nuclear localization and enhanced transcriptional activity; when associated with R-166 and R-399. Primarily nuclear localization and enhanced ATRA-mediated transcriptional activity; when associated with R-147; R-166 and R-399." evidence="21">
<original>K</original>
<variation>R</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on heterodimerization with RARA. On ATRA treatment, localizes to the nucleus, and increased protein levels; when associated with A-369." evidence="23">
<original>S</original>
<variation>A</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on heterodimerization with RARA. On ATRA treatment, localizes to both nucleus and cytoplasm, no increase in protein levels, and decrease in RARA-mediated transcriptional activity; when associated with E-369." evidence="23">
<original>S</original>
<variation>E</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on heterodimerization with RARA. On ATRA treatment, localizes to the nucleus, and increased protein levels; when associated with A-219." evidence="23">
<original>S</original>
<variation>A</variation>
<location>
<position position="369"/>
</location>
</feature>
<feature type="mutagenesis site" description="Some inhibition of heterodimerization with RARA. On ATRA treatment, localizes to both nucleus and cytoplasm, increase in protein levels, and decrease in RARA-mediated transcriptional activity; when associated with E-219." evidence="23">
<original>S</original>
<variation>E</variation>
<location>
<position position="369"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates interaction with NCOR1 or NCOR2. Increased affinity for NCOR1 and NCOR2 in the presence of BMS493. Increased transcriptional activity in the presence of agonist and decreased activity in the presence of neutral antagonist." evidence="24">
<original>I</original>
<variation>E</variation>
<location>
<position position="396"/>
</location>
</feature>
<feature type="mutagenesis site" description="In the absence of ATRA, abolishes sumoylation and is mainly nuclear. In the presence of ATRA, some sumoylation, cytoplasmic location, reduced transcriptional activity and no SENP6 binding. Low sumoylation levels in the presence of ATRA and nuclear location in the absence of ATRA; when associated with R-166 or with R-171. Primarily nuclear localization and enhanced ATRA-mediated transcriptional activity; when associated with R-147; R-166 and R-171." evidence="21">
<original>K</original>
<variation>R</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with ASXL1 and NCOA1." evidence="18">
<original>LI</original>
<variation>AA</variation>
<location>
<begin position="409"/>
<end position="410"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with ASXL1 and NCOA1; when associated with Q-415." evidence="18">
<original>E</original>
<variation>Q</variation>
<location>
<position position="412"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with ASXL1 and NCOA1." evidence="18">
<original>ML</original>
<variation>AA</variation>
<location>
<begin position="413"/>
<end position="414"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with ASXL1 and NCOA1; when associated with Q-412." evidence="18">
<original>E</original>
<variation>Q</variation>
<location>
<position position="415"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAD05222." ref="3" evidence="35">
<original>E</original>
<variation>D</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="89"/>
<end position="91"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="97"/>
<end position="99"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="106"/>
<end position="117"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="134"/>
<end position="136"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="137"/>
<end position="139"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="141"/>
<end position="150"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="155"/>
<end position="157"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="183"/>
<end position="196"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="202"/>
<end position="204"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="214"/>
<end position="216"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="222"/>
<end position="244"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="249"/>
<end position="251"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="254"/>
<end position="275"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="279"/>
<end position="282"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="283"/>
<end position="285"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="289"/>
<end position="293"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="294"/>
<end position="300"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="303"/>
<end position="305"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="306"/>
<end position="316"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="317"/>
<end position="319"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="323"/>
<end position="334"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="345"/>
<end position="366"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="373"/>
<end position="401"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="402"/>
<end position="404"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="408"/>
<end position="414"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1DSZ"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3KMR"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5K13"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P11416"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00407"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01189"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10567404"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10698945"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10882070"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11971969"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12039952"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12691149"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15509776"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15809060"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16179254"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16417524"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16606617"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17455211"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19377461"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19850744"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20078863"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20215566"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20543827"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22351778"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24336203"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26463675"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28167758"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30468856"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8302850"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8562957"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9267036"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11812818"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000305"/>
<evidence key="36" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="30468856"/>
</source>
</evidence>
<sequence length="462" mass="50771" checksum="E8D1CF9A1E57CB99" modified="1989-10-01" version="2">MASNSSSCPTPGGGHLNGYPVPPYAFFFPPMLGGLSPPGALTTLQHQLPVSGYSTPSPATIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRNKKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLEQPDRVDMLQEPLLEALKVYVRKRRPSRPHMFPKMLMKITDLRSISAKGAERVITLKMEIPGSMPPLIQEMLENSEGLDTLSGQPGGGGRDGGGLAPPPGSCSPSLSPSSNRSSPATHSP</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

